High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): A 3-year interim report

Richard A. Nash*, George J. Hutton, Michael K. Racke, Uday Popat, Steven M. Devine, Linda M. Griffith, Paolo A. Muraro, Harry Openshaw, Peter H. Sayre, Olaf Stüve, Douglas L. Arnold, Meagan E. Spychala, Kaitlyn C. McConville, Kristina M. Harris, Deborah Phippard, George E. Georges, Annette Wundes, George H. Kraft, James D. Bowen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

140 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): A 3-year interim report'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

INIS

Neuroscience